NCT07395635 Phase II Trial of Immunonutrition in Hepatectomy
| NCT ID | NCT07395635 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tata Memorial Centre |
| Condition | Hepatocellular Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-03 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-10-03 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Eligibility Criteria
Inclusion Criteria: 1. Patients with liver tumors planned for major hepatectomies (defined as resection of \>/= 3 liver segments) 2. Age above 18 years 3. ASA class I-III Exclusion Criteria: 1. Preoperative severe renal failure (estimated glomerular filtration rate \< 30 ml/min) 2. History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition 4\. Pregnancy 5. Mental condition rendering the subject unable to understand the nature, endpoints and consequences of the trial
Contact & Investigator
Dr. Shraddha Patkar, MD MCh
PRINCIPAL INVESTIGATOR
Professor and surgeon
Frequently Asked Questions
Who can join the NCT07395635 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Hepatocellular Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07395635 currently recruiting?
Yes, NCT07395635 is actively recruiting participants. Contact the research team at drshraddhapatkar@gmail.com for enrollment information.
Where is the NCT07395635 trial being conducted?
This trial is being conducted at Mumbai, India.
Who is sponsoring the NCT07395635 clinical trial?
NCT07395635 is sponsored by Tata Memorial Centre. The principal investigator is Dr. Shraddha Patkar, MD MCh at Professor and surgeon. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.